Fmoc-L-Orn(Fmoc)-OH is a protected amino acid derivative of L-ornithine in which both the α-amino group and the side-chain amino functionality are capped with Fmoc (9H-fluoren-9-ylmethoxycarbonyl) protecting groups, yielding a diamino acid building block for peptide-related synthesis. The molecule contains a free carboxyl group and two Fmoc-protected amines, with the ornithine side chain presenting a protected primary amine that can be unmasked under deprotection conditions to enable controlled chemoselective coupling steps. In solid-phase or solution-phase peptide chemistry, this bis-Fmoc ornithine analogue is used to introduce an ornithine residue bearing orthogonally addressable nitrogen functionalities for preparing peptides, amino acid conjugates, or structure-activity study substrates where side-chain amino presentation is required.
CAT No: CP25566
CAS No:201046-59-5
Synonyms/Alias:Di-Fmoc-L-ornithine;201046-59-5;Fmoc-Orn(Fmoc)-OH;AmbotzFAA1623;SCHEMBL119708;CTK8F9200;HFKOCIWEYMAENQ-YTTGMZPUSA-N;C35H32N2O6;6780AD;CF-207;ZINC71788113;AKOS025289359;AK170056;TR-009365;FT-0679773;Nalpha,Ndelta-di-(9-Fluorenylmethoxycarbonyl)-L-ornithine;(2S)-2,5-Bis(9H-fluorene-9-ylmethoxycarbonylamino)pentanoicacid;(2S)-2,5-bis({[(9H-fluoren-9-ylmethoxy)carbonyl]amino})pentanoicacid
Chemical Name:N-alpha-N-delta-Bis(9-fluorenylmethyloxycarbonyl)-L-ornithine
Fmoc-L-Orn(Fmoc)-OH is a chiral, orthogonally protected amino acid derivative based on L-ornithine, bearing a primary side-chain amine that is additionally protected with an Fmoc group. The molecule contains two Fmoc-protecting groups, providing a bis-Fmoc architecture that supports controlled stepwise deprotection during peptide assembly while maintaining compatibility with standard base-labile Fmoc chemistry. The presence of a free carboxylic acid and two protected nitrogen sites influences solubility, coupling behavior, and downstream derivatization, making it a practical intermediate for constructing polyamine-rich sequences and nitrogen-functionalized scaffolds. The defined stereochemistry at the L-ornithine center and the protected side-chain functionality enable reproducible incorporation into peptide building blocks and synthetic routes that require precise control over amine reactivity.
1. Peptide Synthesis
Fmoc-L-Orn(Fmoc)-OH is used in peptide synthesis workflows to introduce an L-ornithine residue with both the α-amino functionality and the side-chain amine masked as Fmoc carbamates. The dual Fmoc protection pattern supports sequential deprotection and coupling strategies, allowing controlled formation of N-terminal and side-chain-linked amide bonds without premature crosslinking from the polyamine-like side chain. The carboxylic acid group participates in standard peptide coupling chemistry after activation, enabling incorporation into protected amino acid sequences on solid-phase or solution-phase assembly. Downstream peptide products can include polyamine-containing motifs, branched amide architectures, and ornithine-derived linkers that remain stable during iterative synthesis steps.
2. Chemical Biology
Fmoc-L-Orn(Fmoc)-OH is applied in chemical biology for preparing ornithine-based probes and nitrogen-rich molecular tools where selective amine unmasking is required. The protected side-chain amine, revealed by Fmoc removal under base conditions, can be leveraged to generate defined cationic or nucleophilic handles for conjugation to biomolecules, affinity tags, or reporter fragments. The bis-Fmoc design supports stepwise functionalization, reducing the risk of heterogeneous labeling that can arise from uncontrolled polyamine reactivity. Ornithine-derived peptide conjugates and amine-functionalized scaffolds prepared from this intermediate can serve as building blocks for studying biomolecular recognition and for generating defined chemical probes.
3. Bioconjugation Chemistry
Fmoc-L-Orn(Fmoc)-OH is suitable for bioconjugation chemistry that targets controlled installation of amide-linked or amine-reactive moieties onto proteins, peptides, or other biopolymers. The compound's two Fmoc-protected nitrogens enable orthogonal handling in synthetic sequences that require temporary masking of reactive amines during linker construction. After Fmoc deprotection, the resulting free primary amine(s) can be converted into conjugation-ready derivatives such as activated amide-forming intermediates or nucleophile-bearing linkers for subsequent coupling steps. The defined L-ornithine stereocenter and protected-group strategy help maintain structural consistency in conjugate libraries used for biochemical research and applied molecular labeling.
4. Peptidomimetics And Linkers
Fmoc-L-Orn(Fmoc)-OH is employed in peptidomimetic and linker synthesis to build nitrogen-rich scaffolds that mimic polyamine character while retaining synthetic controllability. The protected side-chain amine and α-carboxylic acid functionality support construction of amide and urea-like linkages that can be incorporated into peptide analogs, branching units, or multivalent binding elements. The bis-Fmoc protection pattern supports iterative assembly of complex structures where multiple nitrogens must remain masked until specific coupling or functionalization events. Downstream derivatives can be used to generate structured peptidomimetics, multivalent conjugates, and intermediate fragments for medicinal chemistry-style scaffold diversification.
5. Process Chemistry Intermediate
Fmoc-L-Orn(Fmoc)-OH is relevant to process chemistry intermediate preparation for manufacturing workflows that rely on Fmoc-protected amino acid building blocks. The carboxylic acid and Fmoc-protected amines provide a predictable reactivity profile under peptide-coupling conditions, while the protected nitrogens reduce side reactions associated with free polyamine functionality during scale-up. The stereochemically defined L-ornithine core supports consistent downstream incorporation into peptide-based intermediates and nitrogen-functionalized materials. The compound can be employed as a controlled input for producing protected ornithine-containing sequences, linker fragments, and intermediate feedstocks used in fine chemical synthesis and industrial peptide manufacturing pipelines.
1. Implications of ligand-receptor binding kinetics on GLP-1R signalling
2. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.